Target intelligence / Profile preview

Phosphatidylcholine lipid bilayer (PC bilayer)

Target
PC bilayer
Molecular classification
Lipid, Phospholipid, Membrane component, Other
01

Overview

The phosphatidylcholine lipid bilayer is the primary structural matrix of eukaryotic cell membranes, composed of amphipathic phospholipids with a choline head group and two fatty acid tails (Alberts et al., Molecular Biology of the Cell, 2002). It functions as a selective permeability barrier, maintaining the distinct internal environment of cells and organelles while facilitating the localization and function of membrane-bound proteins (van Meer et al., Nature Reviews Molecular Cell Biology, 2008). In pathophysiology, changes in the composition or fluidity of the PC bilayer are associated with conditions such as respiratory distress syndrome, where surfactant deficiency leads to alveolar collapse, and various metabolic disorders (Agassandian & Mallampalli, Biochimica et Biophysica Acta, 2013). Therapeutic interventions often target the bilayer to either disrupt it, as seen with certain antimicrobial peptides and antifungal agents like Amphotericin B, or to restore its function through lipid replacement therapies (Yeaman & Yount, Pharmacological Reviews, 2003; Escribá et al., Journal of Cellular and Molecular Medicine, 2008). Additionally, the PC bilayer is a critical component in the formulation of liposomal drug delivery systems, which enhance the bioavailability and reduce the toxicity of encapsulated drugs (van Meer et al., 2008). Understanding the biophysical properties of this bilayer is essential for developing treatments that modulate membrane-associated signaling pathways and cellular stability (Escribá et al., 2008).

Other names
Lecithin bilayerPhosphatidylcholine membraneGlycerophosphocholine bilayer
02

Mechanism of action

Membrane disruption, pore formation, and membrane stabilization (Yeaman & Yount, 2003; Escribá et al., 2008)

03

Biological functions

Signal transductionStructural integrityPermeability barrierMembrane fluidityOther
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseInfectionRespiratory distress syndromeOther
05

Safety considerations

HemolysisNon-specific cytotoxicitySystemic inflammatory response
06

Interacting drugs

Amphotericin B

4 more in the full profile.

07

Biomarkers

Lecithin-sphingomyelin ratioPhosphatidylcholine/Phosphatidylethanolamine ratioPlasma choline levels

Beyond the preview

Go deeper on Phosphatidylcholine lipid bilayer (PC bilayer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylcholine lipid bilayer (PC bilayer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call